Managing Post‑Approval Changes and Product Lifecycle in Pharmaceuticals Ensuring Product Excellence: Post‑Approval Changes & Lifecycle Management in Pharma Introduction: Lifecycle Management as a Regulatory Imperative In today’s pharmaceutical environment, obtaining marketing authorization marks the beginning, not the end, of regulatory responsibility. Post-approval changes—ranging from manufacturing site transfers, CMC modifications, labeling updates, to stability extensions—require careful planning, risk assessment, and regulatory filings. Effective lifecycle management ensures product quality, compliance, and market continuity. Agencies like the FDA, EMA, and CDSCO have structured frameworks (Special Supplemental Applications, Type IA/B/II Variations, SUPAC, ICH Q12) to classify changes and guide regulatory expectations. Understanding these pathways…